Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue

Clinical trial NCT01937312 · COMPLETED

Trial details

NCT number: NCT01937312
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Ocular Hypertension Open Angle Glaucoma

Start date: 2013-10-01
Primary completion: 2014-05-01
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.